What is the half-life of amlodipine (calcium channel blocker) benzoate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Half-Life of Amlodipine Benzoate

The half-life of amlodipine is 34-50 hours, making it one of the longest-acting calcium channel blockers available. 1

Pharmacokinetic Profile of Amlodipine

Amlodipine has several distinctive pharmacokinetic properties that contribute to its clinical utility:

  • Elimination half-life: 34-50 hours 1, with some sources reporting 35-50 hours 2 or 36-45 hours 3
  • Absorption: Slow absorption after oral administration, with peak plasma concentrations occurring 6-8 hours after dosing 4
  • Bioavailability: High oral bioavailability (60-80%) 4
  • Metabolism: Extensively metabolized by the liver 5
  • Clearance: Low renal clearance (7 mL/min/mg) 2
  • Steady state: Accumulates to steady-state with once-daily administration over 1-1.5 weeks 4
  • Plasma concentration fluctuation: Minimal (20-25%) between doses with once-daily dosing 4

Clinical Implications of Amlodipine's Long Half-Life

The extended half-life of amlodipine provides several clinical advantages:

  • Sustained blood pressure control: Maintains antihypertensive effect for more than 24 hours following a single dose 2
  • Forgiveness factor: Blood pressure control is maintained even when a dose is missed, providing protection in cases of incidental noncompliance 2
  • Once-daily dosing: The long half-life allows for convenient once-daily administration 3
  • Smooth action: Gradual onset of effect without reflex tachycardia 4
  • Reduced blood pressure variability: The long half-life contributes to reduced fluctuations in blood pressure 2

Special Considerations

  • Hepatic impairment: The plasma elimination half-life increases to 56 hours in patients with impaired hepatic function, requiring slower dose titration in these patients 5
  • Medication adherence monitoring: Due to its long half-life, amlodipine may remain detectable in biological samples for extended periods, which can affect interpretation of adherence testing. A patient may be dosing sporadically but still test positive up to a week after the last ingestion 1
  • Discontinuation: After stopping amlodipine, blood pressure returns to baseline gradually over 7-10 days, without evidence of rebound effect 4

Comparative Half-Lives Among Calcium Channel Blockers

Amlodipine's half-life is significantly longer than other calcium channel blockers, which contributes to its superior 24-hour blood pressure control:

  • Amlodipine: 34-50 hours 1
  • Felodipine: Shorter half-life (comparative study showed amlodipine provided better nighttime blood pressure control) 6
  • Nifedipine: Much shorter half-life (comparative studies show amlodipine's advantages in 24-hour coverage) 3

The long half-life of amlodipine makes it particularly suitable for patients who may occasionally miss doses and for those requiring stable 24-hour blood pressure control.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amlodipine in the current management of hypertension.

Journal of clinical hypertension (Greenwich, Conn.), 2023

Research

Amlodipine: a new calcium antagonist.

American journal of hospital pharmacy, 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.